Morpho CDI is widely used in the pharmaceutical industry as a coupling agent for peptide synthesis. It facilitates the formation of amide bonds between amino acids, ensuring efficient and high-yield production of peptides. This chemical is particularly valued for its ability to minimize racemization, preserving the stereochemical integrity of the peptides during synthesis. Additionally, it is employed in the preparation of various bioactive compounds and complex molecules, making it a crucial tool in drug discovery and development. Its stability and effectiveness under mild reaction conditions further enhance its utility in organic synthesis and bioconjugation processes.